Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Cytoplasmic Ribosomal Proteins WP477,2.2194493425547813e-66,69.21265141318977,10463.108862136745,"['RPL30', 'RPL3', 'RPL32', 'RPL34', 'RPLP1', 'RPL10A', 'RPL8', 'RPL9', 'RPL6', 'RPL7', 'RPS4X', 'RPS15', 'RPL7A', 'RPS14', 'RPS16', 'RPL18A', 'RPS19', 'RPS18', 'RPL36', 'RPL35', 'RPLP2', 'RPL38', 'RPL37', 'RPS11', 'RPL39', 'RPS10', 'RPS13', 'RPS12', 'RPS9', 'RPS7', 'RPL21', 'RPS8', 'RPL23', 'RPS5', 'RPS6', 'RPL22', 'RPSA', 'RPS3A', 'RPL37A', 'RPL24', 'RPL27', 'RPL26', 'RPL29', 'RPL28', 'RPL10', 'RPL12', 'RPL11', 'RPL36A', 'RPS15A', 'RPL14', 'RPS3', 'RPL13', 'RPS2', 'RPS27A', 'RPL18', 'RPL17', 'RPL19', 'RPL41', 'RPL35A', 'RPL23A', 'RPS26', 'RPS25', 'RPS28', 'RPS27', 'RPS29', 'RPL27A', 'FAU', 'RPS21', 'RPS24', 'RPS23']",8.145379087176047e-64,0,0,70
2,Electron Transport Chain (OXPHOS system in mitochondria) WP111,2.942031345427872e-35,24.646883963494133,1959.7077068063877,"['NDUFB9', 'COX7B', 'NDUFB8', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFA12', 'NDUFB5', 'COX4I1', 'COX17', 'NDUFB3', 'ATP5MC2', 'NDUFB2', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX5B', 'COX7A1', 'COX7C', 'UQCRH', 'ATP5MC1', 'ATP5IF1', 'COX11', 'UQCRFS1', 'ATP5MG', 'ATP5MF', 'ATP5ME', 'COX8A', 'ATP5PF', 'SURF1', 'NDUFA7', 'ATP5PD', 'NDUFA6', 'NDUFA5', 'NDUFA2', 'NDUFA1', 'NDUFC1', 'COX6C', 'ATP5F1E', 'COX6B1', 'UQCRQ', 'NDUFS6', 'NDUFS5', 'ATP5PO', 'SLC25A5']",5.398627518860145e-33,0,0,46
3,Oxidative phosphorylation WP623,3.1994970494009583e-16,16.628902953586497,593.2921167281058,"['NDUFB9', 'ATP5PF', 'NDUFB8', 'NDUFA7', 'NDUFB7', 'NDUFA6', 'ATP5PD', 'NDUFB10', 'NDUFA5', 'NDUFB5', 'NDUFA2', 'ATP5MC2', 'NDUFB2', 'NDUFB1', 'NDUFC1', 'ATP5F1E', 'ATP5MC1', 'NDUFS6', 'NDUFS5', 'ATP5PO', 'ATP5MG', 'ATP5MF', 'ATP5ME']",3.914051390433839e-14,0,0,23
4,Nonalcoholic fatty liver disease WP4396,6.49460458997995e-16,6.67917666996187,233.57341114912484,"['NDUFB9', 'NDUFA13', 'COX7B', 'NDUFB8', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFA12', 'NDUFB5', 'COX4I1', 'NDUFB3', 'NDUFB2', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX5B', 'COX7A1', 'COX7C', 'UQCRH', 'MLX', 'UQCRFS1', 'COX8A', 'NDUFA7', 'NDUFA6', 'NDUFA5', 'NDUFA2', 'NDUFA1', 'NDUFC1', 'COX6C', 'COX6B1', 'UQCRQ', 'NDUFS6', 'DDIT3', 'NDUFS5', 'CYCS', 'BAX']",5.833123304284588e-14,0,0,37
5,Mitochondrial CIV Assembly WP4922,7.947034474502162e-16,27.35936188077246,951.2456876403846,"['COX8A', 'COA3', 'COX7B', 'SURF1', 'COX16', 'PET100', 'TACO1', 'COX4I1', 'COX17', 'COX7A2', 'COX5B', 'COX6C', 'COX7C', 'PET117', 'COX6B1', 'SCO2', 'COX11', 'COX14', 'COX20']",5.833123304284588e-14,0,0,19
6,Mitochondrial complex I assembly model OXPHOS system WP4324,4.619453519793391e-15,17.040956439393938,562.496410332751,"['NDUFB9', 'NDUFA13', 'NDUFB8', 'NDUFA7', 'NDUFB7', 'NDUFA6', 'DMAC1', 'NDUFB10', 'NDUFA5', 'NDUFA12', 'NDUFB5', 'NDUFB3', 'NDUFA2', 'NDUFB2', 'NDUFA1', 'NDUFB1', 'NDUFC1', 'TMEM186', 'NDUFS6', 'NDUFS5', 'TMEM126B']",2.825565736273624e-13,0,0,21
7,Mitochondrial complex III assembly WP4921,2.7818599503941784e-06,22.352667493796528,285.9440581611228,"['UQCRB', 'UQCC3', 'UQCRQ', 'UQCRFS1', 'UQCR11', 'UQCR10', 'UQCRH']",0.00014584894311352336,0,0,7
8,Cellular Proteostasis WP4918,0.0003786354204643089,25.45611866501854,200.5671492983767,"['VBP1', 'PFDN4', 'PFDN5', 'PFDN6']",0.01736989991380017,0,0,4
9,Pyrimidine metabolism WP4022,0.0013335681156145902,3.3495724973281082,22.173825379611877,"['NT5C', 'POLE4', 'POLD4', 'POLR3GL', 'POLE3', 'NME2', 'TK1', 'POLR2I', 'POLR2K', 'NME1', 'POLR2L']",0.054379944270061625,0,0,11
10,Proteasome Degradation WP183,0.007312928359773014,3.5691315136476427,17.553386703113777,"['PSMB6', 'PSMC5', 'PSMD7', 'H2AFZ', 'HLA-B', 'PSMB10', 'PSMB9']",0.2683844708036696,0,0,7
11,Sleep regulation WP3591,0.009765379077702552,3.821189591078067,17.687949952589047,"['CACNA1I', 'IL18', 'CRH', 'DRD1', 'BTBD9', 'HCRTR1']",0.2986578434597364,0,0,6
12,Nucleotide Excision Repair WP4753,0.009765379077702552,3.821189591078067,17.687949952589047,"['POLE4', 'POLD4', 'RFC2', 'POLE3', 'MNAT1', 'GTF2H5']",0.2986578434597364,0,0,6
13,DNA Mismatch Repair WP531,0.011922838515138114,5.65306963329213,25.039138586295962,"['POLE4', 'POLD4', 'RFC2', 'POLE3']",0.33390725557512735,0,0,4
14,Base Excision Repair WP4752,0.01273760647970513,4.242574257425742,18.511185239758245,"['POLE4', 'POLD4', 'TDG', 'APEX1', 'POLE3']",0.33390725557512735,0,0,5
15,Macrophage markers WP4146,0.016536244468962874,7.6251851851851855,31.280039795879173,"['CD163', 'CD14', 'CD68']",0.3997574005335723,0,0,3
16,Selenium Micronutrient Network WP15,0.017428115554597157,2.495051914341337,10.104138234151307,"['SELENOM', 'PRDX5', 'SELENOS', 'ALOX5', 'ALOX5AP', 'SELENOW', 'TXN', 'PTGS1', 'SELENOH']",0.3997574005335723,0,0,9
17,mRNA Processing WP411,0.02166541322980786,2.390625,9.160966203204337,"['LSM7', 'SNRPD1', 'CELF1', 'SNRPG', 'SNRPE', 'SNRPB2', 'SNRPF', 'SRSF9', 'LSM2']",0.46771803854938154,0,0,9
18,Microglia Pathogen Phagocytosis Pathway WP3937,0.026487998320799074,2.9376608521589933,10.666833219422866,"['NCF2', 'ARPC1B', 'NCF4', 'ITGB2', 'CYBB', 'CYBA']",0.5295460233494264,0,0,6
19,Hijack of ubiquitination by SARS-CoV-2 WP4860,0.029044044245475513,12.696670776818742,44.93277936550554,"['ELOB', 'ELOC']",0.5295460233494264,0,0,2
20,Cytokines and Inflammatory Response WP530,0.03174390330705008,5.445502645502645,18.787281418250114,"['CD4', 'HLA-DRA', 'HLA-DRB1']",0.5295460233494264,0,0,3
21,Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells WP4301,0.03174390330705008,5.445502645502645,18.787281418250114,"['RRAS2', 'MAPK1', 'HRAS']",0.5295460233494264,0,0,3
22,nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell WP5027,0.03174390330705008,5.445502645502645,18.787281418250114,"['EIF2S2', 'EIF3D', 'EIF1']",0.5295460233494264,0,0,3
23,ERK Pathway in Huntington's Disease WP3853,0.04132672280618455,4.764351851851852,15.180396777778824,"['NTRK2', 'MAPK1', 'HRAS']",0.6204752947512457,0,0,3
24,Pathogenesis of SARS-CoV-2 Mediated by nsp9-nsp10 Complex WP4884,0.04132672280618455,4.764351851851852,15.180396777778824,"['CD4', 'HLA-DRA', 'HLA-DRB1']",0.6204752947512457,0,0,3
25,DNA Repair Pathways Full Network WP4946,0.04226670945171974,2.0849389416553596,6.596237071729,"['POLE4', 'POLD4', 'CENPX', 'RFC2', 'TDG', 'APEX1', 'POLE3', 'MNAT1', 'GTF2H5']",0.6204752947512457,0,0,9
26,Nanomaterial induced apoptosis WP2507,0.06426295586755232,3.8107407407407408,10.459614209274577,"['ENDOG', 'BAX', 'CYCS']",0.7792516537338636,0,0,3
27,Overview of nanoparticle effects WP3287,0.06426295586755232,3.8107407407407408,10.459614209274577,"['COL4A1', 'BAX', 'PTGS1']",0.7792516537338636,0,0,3
28,Arachidonate Epoxygenase / Epoxide Hydrolase WP678,0.06582234677316015,6.347102342786683,17.269169914945348,"['COX8A', 'CYP2C8']",0.7792516537338636,0,0,2
29,Cytosine methylation WP3585,0.06582234677316015,6.347102342786683,17.269169914945348,"['TDG', 'IDH2']",0.7792516537338636,0,0,2
30,Dual hijack model of Vif in HIV infection WP3300,0.06582234677316015,6.347102342786683,17.269169914945348,"['ELOB', 'ELOC']",0.7792516537338636,0,0,2
31,Nanoparticle triggered regulated necrosis WP2513,0.06582234677316015,6.347102342786683,17.269169914945348,"['TRADD', 'FTL']",0.7792516537338636,0,0,2
32,Eukaryotic Transcription Initiation WP405,0.07247823681569952,2.8240626287597856,7.411664665197015,"['GTF2A2', 'POLR2I', 'MNAT1', 'POLR2K']",0.81367134373927,0,0,4
33,Mitochondrial CII Assembly WP4920,0.0731639082926319,inf,inf,['SDHAF1'],0.81367134373927,0,0,1
34,Eicosanoid Synthesis WP167,0.0774957975222421,3.463973063973064,8.859220467398622,"['ALOX5', 'ALOX5AP', 'PTGS1']",0.836498755607731,0,0,3
35,Translation Factors WP107,0.08963351580863009,2.2699345827439887,5.475141160556793,"['EEF1B2', 'EIF1AY', 'EIF2S2', 'EIF3D', 'EIF1']",0.9398714371933498,0,0,5
36,Copper homeostasis WP3286,0.09397573345172903,2.5411619283065514,6.009133092990885,"['SCO2', 'COX17', 'COX11', 'ATOX1']",0.958030393799571,0,0,4
37,Cytosolic DNA-sensing pathway WP4655,0.09909518138207388,2.1914475930351656,5.065913436993341,"['POLR3GL', 'TRADD', 'IL18', 'POLR2K', 'POLR2L']",0.9829170693843544,0,0,5
38,TYROBP causal network in microglia WP3945,0.10465147242747766,1.8547611662531018,4.186418078746224,"['CD4', 'SLC7A7', 'NCF2', 'ITGB2', 'IL18', 'CYTL1', 'SLC1A5']",0.9979003388417151,0,0,7
39,Kallmann's Syndrome WP5074,0.10711529720199227,2.9304843304843304,6.546260899881637,"['MAPK1', 'GNRH1', 'FRS2']",0.9979003388417151,0,0,3
40,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.12333300658515661,2.7208994708994707,5.6944812879571165,"['H2AFJ', 'H2AFZ', 'MAPK1']",0.9979003388417151,0,0,3
41,TCA Cycle (aka Krebs or citric acid cycle) WP78,0.13668958231977119,3.6258587282015147,7.215613861881493,"['IDH2', 'IDH3B']",0.9979003388417151,0,0,2
42,Type II interferon signaling (IFNG) WP619,0.14037122701272572,2.5392592592592593,4.985746031937529,"['HLA-B', 'CYBB', 'PSMB9']",0.9979003388417151,0,0,3
43,Gastric Cancer Network 2 WP2363,0.14037122701272572,2.5392592592592593,4.985746031937529,"['AHCTF1', 'S100A6', 'COL9A3']",0.9979003388417151,0,0,3
44,IL-2 signaling pathway WP49,0.1446130393891426,2.1168108776267,4.093264065057744,"['RPS6', 'MAPK1', 'HRAS', 'CRKL']",0.9979003388417151,0,0,4
45,Regulation of Actin Cytoskeleton WP51,0.14837160643966318,1.5144102472869596,2.889548207210096,"['FGF17', 'CHRM3', 'TMSB4X', 'CHRM5', 'BRK1', 'RRAS2', 'MAPK1', 'CD14', 'FGF1', 'PAK4']",0.9979003388417151,0,0,10
46,MET in type 1 papillary renal cell carcinoma WP4205,0.15325939702475283,1.8682658707047175,3.5041631616784286,"['RPL11', 'MAPK1', 'HRAS', 'CRKL', 'PAK4']",0.9979003388417151,0,0,5
47,Serotonin and anxiety WP3947,0.16292601504648418,3.1723181257706536,5.756041417285986,"['POMC', 'CRH']",0.9979003388417151,0,0,2
48,"GPCRs, Class B Secretin-like WP334",0.16292601504648418,3.1723181257706536,5.756041417285986,"['ADGRE1', 'ADGRL2']",0.9979003388417151,0,0,2
49,TNF-alpha signaling pathway WP231,0.16567135866523158,1.6175953079178886,2.908030703136401,"['TRADD', 'MAPK1', 'BAX', 'CYBA', 'TXN', 'BTRC', 'HRAS']",0.9979003388417151,0,0,7
50,Acute viral myocarditis WP4298,0.16682461550704888,1.6941759603469642,3.033951021028282,"['CD4', 'ENDOG', 'ITGB2', 'MAPK1', 'CYCS', 'BAX']",0.9979003388417151,0,0,6
51,GABA receptor Signaling WP4159,0.17654855842049091,2.240087145969499,3.8846680060900254,"['GABRB3', 'SLC32A1', 'GABRA4']",0.9979003388417151,0,0,3
52,Fatty acid transporters WP5061,0.18994808943363842,2.8195643238799835,4.683308910619321,"['FABP6', 'DBI']",0.9979003388417151,0,0,2
53,LTF danger signal response pathway WP4478,0.18994808943363842,2.8195643238799835,4.683308910619321,"['MAPK1', 'CD14']",0.9979003388417151,0,0,2
54,Kit receptor signaling pathway WP304,0.1905391980313553,1.7162831147979662,2.8454212135213157,"['RPS6', 'GRB10', 'MAPK1', 'HRAS', 'CRKL']",0.9979003388417151,0,0,5
55,mBDNF and proBDNF regulation of GABA neurotransmission WP4829,0.1955091348502124,2.115432098765432,3.452698639488283,"['GABRB3', 'NTRK2', 'GABRA4']",0.9979003388417151,0,0,3
56,Heme Biosynthesis WP561,0.20384169382099085,6.3405172413793105,10.084032152121368,['HMBS'],0.9979003388417151,0,0,1
57,Metabolism of alpha-linolenic acid WP4586,0.20384169382099085,6.3405172413793105,10.084032152121368,['ALOX5'],0.9979003388417151,0,0,1
58,MAPK Cascade WP422,0.2149350692207171,2.003898635477583,3.080832437609905,"['RASA3', 'MAPK1', 'HRAS']",0.9979003388417151,0,0,3
59,IL-18 signaling pathway WP4754,0.22182889384521834,1.2901452903085378,1.9427639213845067,"['NRN1', 'NCF2', 'COX17', 'IL18', 'TNFRSF11B', 'NDUFC1', 'RND2', 'RASA3', 'NACA', 'TMSB4X', 'CYCS', 'MAPK1', 'BAX', 'RPS11']",0.9979003388417151,0,0,14
60,BDNF-TrkB Signaling WP3676,0.23474286721003426,1.9035185185185186,2.7587019014998932,"['NTRK2', 'MAPK1', 'HRAS']",0.9979003388417151,0,0,3
61,CAMKK2  Pathway WP4874,0.23474286721003426,1.9035185185185186,2.7587019014998932,"['CHRM3', 'FIS1', 'MAPK1']",0.9979003388417151,0,0,3
62,Type II diabetes mellitus WP1584,0.24536225608659834,2.3064678847662816,3.240632502324945,"['SURF1', 'MAPK1']",0.9979003388417151,0,0,2
63,Hypertrophy Model WP516,0.24536225608659834,2.3064678847662816,3.240632502324945,"['IFRD1', 'IL18']",0.9979003388417151,0,0,2
64,Signaling of Hepatocyte Growth Factor Receptor WP313,0.25485245853996163,1.8126984126984127,2.478086516758819,"['MAPK1', 'HRAS', 'CRKL']",0.9979003388417151,0,0,3
65,p38 MAPK Signaling Pathway WP400,0.25485245853996163,1.8126984126984127,2.478086516758819,"['TRADD', 'DDIT3', 'HRAS']",0.9979003388417151,0,0,3
66,MED and Pseudoachondroplasia genes WP4789,0.26210759031563896,4.226600985221675,5.6594196044945715,['COL9A3'],0.9979003388417151,0,0,1
67,Mevalonate pathway WP3963,0.26210759031563896,4.226600985221675,5.6594196044945715,['PMVK'],0.9979003388417151,0,0,1
68,Serotonin Receptor 2 and ELK-SRF/GATA4 signaling WP732,0.2733400001546186,2.1140567200986435,2.7420136693347086,"['MAPK1', 'HRAS']",0.9979003388417151,0,0,2
69,Splicing factor NOVA regulated synaptic proteins WP4148,0.27518760102411965,1.7301346801346802,2.232396633133945,"['KCNQ2', 'GRIK2', 'ANK3']",0.9979003388417151,0,0,3
70,Bladder cancer WP2828,0.27518760102411965,1.7301346801346802,2.232396633133945,"['DAPK1', 'MAPK1', 'HRAS']",0.9979003388417151,0,0,3
71,Modulators of TCR signaling and T cell activation WP5072,0.28470681512990825,1.5381503539723564,1.9323711327592543,"['NDUFB10', 'RHOH', 'ELOB', 'RNF7']",0.9979003388417151,0,0,4
72,NRF2 pathway WP2884,0.2926657624459717,1.3022455805064501,1.600100481500985,"['SERPINA1', 'SLC6A9', 'FTH1', 'ME1', 'TXN', 'SLC6A20', 'SLC5A3', 'FTL']",0.9979003388417151,0,0,8
73,Monoamine GPCRs WP58,0.29567617426299697,1.6547504025764896,2.0162975285646674,"['CHRM3', 'CHRM5', 'DRD1']",0.9979003388417151,0,0,3
74,TP53 network WP1742,0.3012681014057496,1.9512472730721806,2.341018102981539,"['SUMO1', 'BAX']",0.9979003388417151,0,0,2
75,TCA Cycle Nutrient Utilization and Invasiveness of Ovarian Cancer WP2868,0.31611422401326444,3.169642857142857,3.650324465366402,['MAPK1'],0.9979003388417151,0,0,1
76,Benzo(a)pyrene metabolism WP696,0.31611422401326444,3.169642857142857,3.650324465366402,['AKR1A1'],0.9979003388417151,0,0,1
77,"Cerebral organic acidurias, including diseases WP4519",0.31611422401326444,3.169642857142857,3.650324465366402,['IDH2'],0.9979003388417151,0,0,1
78,Valproic acid pathway WP3871,0.31611422401326444,3.169642857142857,3.650324465366402,['HSD17B10'],0.9979003388417151,0,0,1
79,Mevalonate arm of cholesterol biosynthesis pathway WP4190,0.31611422401326444,3.169642857142857,3.650324465366402,['PMVK'],0.9979003388417151,0,0,1
80,Peroxiredoxin 2 induced ovarian failure WP4873,0.31611422401326444,3.169642857142857,3.650324465366402,['BAX'],0.9979003388417151,0,0,1
81,Ebstein-Barr virus LMP1 signaling WP262,0.32900421305839395,1.8116963184780694,2.0140351193335775,"['TRADD', 'MAPK1']",0.9979003388417151,0,0,2
82,Interleukin-11 Signaling Pathway WP2332,0.3368468564352259,1.5220740740740741,1.6562097192235965,"['RPS6', 'MAPK1', 'HRAS']",0.9979003388417151,0,0,3
83,Allograft Rejection WP2328,0.3525646609755794,1.3713293021080413,1.4296399219591935,"['HLA-B', 'HLA-DRA', 'HLA-DOA', 'HLA-DRB1']",0.9979003388417151,0,0,4
84,Prader-Willi and Angelman Syndrome WP3998,0.3525646609755794,1.3713293021080413,1.4296399219591935,"['GABRB3', 'POMC', 'FEZ1', 'GNRH1']",0.9979003388417151,0,0,4
85,Follicle Stimulating Hormone (FSH) signaling pathway WP2035,0.3564270356235162,1.6907521578298397,1.7442234269281227,"['RPS6', 'MAPK1']",0.9979003388417151,0,0,2
86,IL1 and megakaryocytes in obesity WP2865,0.3564270356235162,1.6907521578298397,1.7442234269281227,"['TLR1', 'IL18']",0.9979003388417151,0,0,2
87,"Relationship between inflammation, COX-2 and EGFR WP4483",0.3564270356235162,1.6907521578298397,1.7442234269281227,"['MAPK1', 'HRAS']",0.9979003388417151,0,0,2
88,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.35740674164045216,1.4633903133903134,1.5056542159960957,"['NTRK2', 'MAPK1', 'HRAS']",0.9979003388417151,0,0,3
89,Ferroptosis WP4313,0.35740674164045216,1.4633903133903134,1.5056542159960957,"['FTH1', 'CYBB', 'FTL']",0.9979003388417151,0,0,3
90,Serotonin and anxiety-related events WP3944,0.3661725918515051,2.5354679802955666,2.5472591596745784,['CRH'],0.9979003388417151,0,0,1
91,Aspirin and miRNAs WP4707,0.3661725918515051,2.5354679802955666,2.5472591596745784,['PTGS1'],0.9979003388417151,0,0,1
92,Eicosanoid metabolism via cytochrome P450 monooxygenases (CYP) pathway WP4720,0.3661725918515051,2.5354679802955666,2.5472591596745784,['CYP2C8'],0.9979003388417151,0,0,1
93,MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma WP3593,0.3661725918515051,2.5354679802955666,2.5472591596745784,['VEGFB'],0.9979003388417151,0,0,1
94,Nanoparticle-mediated activation of receptor signaling WP2643,0.3834340051620031,1.5849260172626387,1.519290678451049,"['MAPK1', 'HRAS']",0.9979003388417151,0,0,2
95,Parkinson's disease pathway WP2371,0.3834340051620031,1.5849260172626387,1.519290678451049,"['CYCS', 'PARK7']",0.9979003388417151,0,0,2
96,PI3K-AKT-mTOR signaling pathway and therapeutic opportunities WP3844,0.3834340051620031,1.5849260172626387,1.519290678451049,"['GRB10', 'HRAS']",0.9979003388417151,0,0,2
97,PPAR signaling pathway WP3942,0.38664493768703834,1.300751164780831,1.2360368181873818,"['FABP6', 'ME1', 'DBI', 'CPT1B']",0.9979003388417151,0,0,4
98,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.39820367400053774,1.3585978835978836,1.2509856016978849,"['NDUFA13', 'COPS6', 'IL18']",0.9979003388417151,0,0,3
99,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.4036091523898363,1.2681087762669963,1.150565635607628,"['APEX1', 'RPS6', 'MAPK1', 'HRAS']",0.9979003388417151,0,0,4
100,Type 2 papillary renal cell carcinoma WP4241,0.4099392067046325,1.4915500108798143,1.3300843624781529,"['ELOB', 'ELOC']",0.9979003388417151,0,0,2
101,Disruption of postsynaptic signaling by CNV WP4875,0.4099392067046325,1.4915500108798143,1.3300843624781529,"['MAPK1', 'DLGAP1']",0.9979003388417151,0,0,2
102,Glycosylation and related congenital defects WP4521,0.4099392067046325,1.4915500108798143,1.3300843624781529,"['DPM2', 'DPM3']",0.9979003388417151,0,0,2
103,TCA cycle in senescence WP5050,0.41257100944823355,2.1126847290640396,1.8704589683128143,['ME1'],0.9979003388417151,0,0,1
104,Bile acids synthesis and enterohepatic circulation  WP4389,0.41257100944823355,2.1126847290640396,1.8704589683128143,['MAPK1'],0.9979003388417151,0,0,1
105,BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation WP3876,0.41257100944823355,2.1126847290640396,1.8704589683128143,['SST'],0.9979003388417151,0,0,1
106,Codeine and Morphine Metabolism WP1604,0.41257100944823355,2.1126847290640396,1.8704589683128143,['CYP2C8'],0.9979003388417151,0,0,1
107,Homologous recombination WP186,0.41257100944823355,2.1126847290640396,1.8704589683128143,['POLD4'],0.9979003388417151,0,0,1
108,Insulin signaling in adipocytes (diabetic condition) WP3635,0.41257100944823355,2.1126847290640396,1.8704589683128143,['RPS6'],0.9979003388417151,0,0,1
109,Insulin signaling in adipocytes (normal condition) WP3634,0.41257100944823355,2.1126847290640396,1.8704589683128143,['RPS6'],0.9979003388417151,0,0,1
110,MFAP5-mediated ovarian cancer cell motility and invasiveness WP3301,0.41257100944823355,2.1126847290640396,1.8704589683128143,['MAPK1'],0.9979003388417151,0,0,1
111,Purine metabolism WP4792,0.41257100944823355,2.1126847290640396,1.8704589683128143,['APRT'],0.9979003388417151,0,0,1
112,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.4275857967418479,1.127287784679089,0.9577440587724944,"['GABRB3', 'NTRK2', 'NCF2', 'RPS6', 'MAPK1', 'FRS2', 'EIF2S2', 'HRAS']",0.9979003388417151,0,0,8
113,Type I collagen synthesis in the context of Osteogenesis imperfecta WP4786,0.43587149176342127,1.4085491163173038,1.16967020490401,"['TNFRSF11B', 'PPIB']",0.9979003388417151,0,0,2
114,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.4498482763580706,1.1525652565256526,0.9207208963623855,"['RPS6', 'RRAS2', 'MAPK1', 'BAX', 'HRAS']",0.9979003388417151,0,0,5
115,Ciliary landscape WP4352,0.4525739951642268,1.0837564262221797,0.8592064340546515,"['COPS6', 'IFT22', 'PSMD7', 'NDUFA5', 'SSNA1', 'MYL6B', 'TMED1', 'SNRPB2', 'COX6C', 'LSM4']",0.9979003388417151,0,0,10
116,Endometrial cancer WP4155,0.4538594540737966,1.1792911144967948,0.9316018909921417,"['MAPK1', 'BAX', 'FGF1', 'HRAS']",0.9979003388417151,0,0,4
117,Somitogenesis in the context of spondylocostal dysostosis WP4785,0.45557676320629203,1.8106966924700916,1.4235535362925738,['DLL3'],0.9979003388417151,0,0,1
118,Biomarkers for pyrimidine metabolism disorders WP4584,0.45557676320629203,1.8106966924700916,1.4235535362925738,['NT5C'],0.9979003388417151,0,0,1
119,Cancer immunotherapy by CTLA4 blockade WP4582,0.45557676320629203,1.8106966924700916,1.4235535362925738,['HLA-DRB1'],0.9979003388417151,0,0,1
120,Iron metabolism in placenta WP2007,0.45557676320629203,1.8106966924700916,1.4235535362925738,['FTH1'],0.9979003388417151,0,0,1
121,Mammary gland development pathway - Involution (Stage 4 of 4) WP2815,0.45557676320629203,1.8106966924700916,1.4235535362925738,['BAX'],0.9979003388417151,0,0,1
122,Osteoclast Signaling WP12,0.45557676320629203,1.8106966924700916,1.4235535362925738,['TNFRSF11B'],0.9979003388417151,0,0,1
123,Fluoropyrimidine Activity WP1601,0.4611727822273122,1.3342851580245312,1.0327133722575048,"['TDG', 'TK1']",0.9979003388417151,0,0,2
124,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.46440247317385125,1.1318732319660538,0.8681509609774205,"['POMC', 'RPS6', 'MAPK1', 'FRS2', 'HRAS']",0.9979003388417151,0,0,5
125,VEGFA-VEGFR2 Signaling Pathway WP3888,0.4686979842056848,1.037038429544269,0.7858642736342086,"['NCF2', 'RPS6', 'IDH2', 'CYBB', 'FRS2', 'TXN', 'RPL10A', 'RPL7', 'CYP2C8', 'RPL18A', 'TMSB4X', 'GRB10', 'RPLP2', 'CYCS', 'MAPK1', 'RPL27', 'RPL26', 'ELOC', 'RPS11', 'TMSB10', 'EIF3D', 'HRAS']",0.9979003388417151,0,0,22
126,p53 transcriptional gene network WP4963,0.4772576843812607,1.1883101851851852,0.8789915171583457,"['SIVA1', 'NCF2', 'BAX']",0.9979003388417151,0,0,3
127,22q11.2 copy number variation syndrome WP4657,0.47883920242223427,1.1119072433559145,0.8187978555523322,"['RANBP1', 'P2RX6', 'MRPL40', 'CRKL', 'PAK4']",0.9979003388417151,0,0,5
128,Alzheimer's disease WP2059,0.4865775821140709,1.1266584260403791,0.8115984471650584,"['ATP5MD', 'MAPK1', 'CYCS', 'HSD17B10']",0.9979003388417151,0,0,4
129,Small Ligand GPCRs WP247,0.4954376419345382,1.5842056650246306,1.1126094719133361,['PTAFR'],0.9979003388417151,0,0,1
130,Tamoxifen metabolism WP691,0.4954376419345382,1.5842056650246306,1.1126094719133361,['CYP2C8'],0.9979003388417151,0,0,1
131,Farnesoid X receptor pathway WP2879,0.4954376419345382,1.5842056650246306,1.1126094719133361,['SLCO2B1'],0.9979003388417151,0,0,1
132,IL-9 signaling pathway WP22,0.4954376419345382,1.5842056650246306,1.1126094719133361,['MAPK1'],0.9979003388417151,0,0,1
133,MAP3K1 role in promoting and blocking gonadal determination WP4872,0.4954376419345382,1.5842056650246306,1.1126094719133361,['MAPK1'],0.9979003388417151,0,0,1
134,Osteoblast Signaling WP322,0.4954376419345382,1.5842056650246306,1.1126094719133361,['TNFRSF11B'],0.9979003388417151,0,0,1
135,Osteopontin Signaling WP1434,0.4954376419345382,1.5842056650246306,1.1126094719133361,['MAPK1'],0.9979003388417151,0,0,1
136,Pyrimidine metabolism and related diseases WP4225,0.4954376419345382,1.5842056650246306,1.1126094719133361,['NT5C'],0.9979003388417151,0,0,1
137,RalA downstream regulated genes WP2290,0.4954376419345382,1.5842056650246306,1.1126094719133361,['HRAS'],0.9979003388417151,0,0,1
138,IL-3 signaling pathway WP286,0.4962798783590968,1.1521885521885522,0.8072408596077774,"['MAPK1', 'HRAS', 'CRKL']",0.9979003388417151,0,0,3
139,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.5097064039347979,1.2069755152369208,0.8134054191092681,"['DDIT3', 'MAPK1']",0.9979003388417151,0,0,2
140,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.5097064039347979,1.2069755152369208,0.8134054191092681,"['MAPK1', 'BAX']",0.9979003388417151,0,0,2
141,Non-small cell lung cancer WP4255,0.518472509546268,1.078505115324935,0.7084357913552918,"['MAPK1', 'CYCS', 'BAX', 'HRAS']",0.9979003388417151,0,0,4
142,7q11.23 copy number variation syndrome WP4932,0.521295977641516,1.0560024752475248,0.6879194047033026,"['RFC2', 'ATP5MC2', 'ATP5PO', 'ATP5F1E', 'ATP5MC1']",0.9979003388417151,0,0,5
143,Genes targeted by miRNAs in adipocytes WP1992,0.532383357527242,1.4080459770114941,0.8876201483394108,['TMSB4X'],0.9979003388417151,0,0,1
144,MAPK and NFkB signaling pathways inhibited by Yersinia YopJ WP3849,0.532383357527242,1.4080459770114941,0.8876201483394108,['MAPK1'],0.9979003388417151,0,0,1
145,MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement WP4560,0.532383357527242,1.4080459770114941,0.8876201483394108,['MAPK1'],0.9979003388417151,0,0,1
146,miR-509-3p alteration of YAP1/ECM axis WP3967,0.532383357527242,1.4080459770114941,0.8876201483394108,['GPC6'],0.9979003388417151,0,0,1
147,Regulation of sister chromatid separation at the metaphase-anaphase transition WP4240,0.532383357527242,1.4080459770114941,0.8876201483394108,['ANAPC11'],0.9979003388417151,0,0,1
148,Endothelin Pathways WP2197,0.5328749314482133,1.152000896760453,0.7251483139707845,"['RIIAD1', 'MAPK1']",0.9979003388417151,0,0,2
149,PDGF Pathway WP2526,0.5328749314482133,1.152000896760453,0.7251483139707845,"['MAPK1', 'HRAS']",0.9979003388417151,0,0,2
150,T-cell receptor (TCR) signaling pathway WP69,0.5340669117135723,1.0559332509270705,0.6623173898616782,"['CD4', 'MAPK1', 'HRAS', 'CRKL']",0.9979003388417151,0,0,4
151,Leptin signaling pathway WP2034,0.5340669117135723,1.0559332509270705,0.6623173898616782,"['RPS6', 'MAPK1', 'BAX', 'HRAS']",0.9979003388417151,0,0,4
152,Complement system WP2806,0.5351190514760695,1.038589514689174,0.6493947433949314,"['FCGR3A', 'RPS19', 'ITGB2', 'VSIG4', 'TXN']",0.9979003388417151,0,0,5
153,Apoptosis Modulation and Signaling WP1772,0.5487575622691042,1.021738262535931,0.6131436332621895,"['ENDOG', 'TRADD', 'CYCS', 'BAX', 'TNFRSF11B']",0.9979003388417151,0,0,5
154,Common Pathways Underlying Drug Addiction WP2636,0.5552825117009733,1.1018066798906343,0.648168921632151,"['MAPK1', 'DRD1']",0.9979003388417151,0,0,2
155,Heart Development WP1591,0.5552825117009733,1.1018066798906343,0.648168921632151,"['VEGFB', 'MAPK1']",0.9979003388417151,0,0,2
156,Selective expression of chemokine receptors during T-cell polarization WP4494,0.5666268622384419,1.2671182266009853,0.7197919359183326,['CD4'],0.9979003388417151,0,0,1
157,"4-hydroxytamoxifen, Dexamethasone, and Retinoic Acids Regulation of p27 Expression WP3879",0.5666268622384419,1.2671182266009853,0.7197919359183326,['MAPK1'],0.9979003388417151,0,0,1
158,Apoptosis Modulation by HSP70 WP384,0.5666268622384419,1.2671182266009853,0.7197919359183326,['CYCS'],0.9979003388417151,0,0,1
159,Development and heterogeneity of the ILC family WP3893,0.5666268622384419,1.2671182266009853,0.7197919359183326,['IL18'],0.9979003388417151,0,0,1
160,Galanin receptor pathway WP4970,0.5666268622384419,1.2671182266009853,0.7197919359183326,['POMC'],0.9979003388417151,0,0,1
161,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.5666268622384419,1.2671182266009853,0.7197919359183326,['RPS6'],0.9979003388417151,0,0,1
162,Host-pathogen interaction of human coronaviruses - apoptosis WP4864,0.5666268622384419,1.2671182266009853,0.7197919359183326,['BAX'],0.9979003388417151,0,0,1
163,MTHFR deficiency WP4288,0.5666268622384419,1.2671182266009853,0.7197919359183326,['CYCS'],0.9979003388417151,0,0,1
164,NOTCH1 regulation of endothelial cell calcification WP3413,0.5666268622384419,1.2671182266009853,0.7197919359183326,['DLL3'],0.9979003388417151,0,0,1
165,Nucleotide metabolism WP404,0.5666268622384419,1.2671182266009853,0.7197919359183326,['NME2'],0.9979003388417151,0,0,1
166,Purine metabolism and related disorders WP4224,0.5666268622384419,1.2671182266009853,0.7197919359183326,['APRT'],0.9979003388417151,0,0,1
167,Vitamin D Receptor Pathway WP2877,0.5704612819857121,0.9837544473255744,0.5521911879644903,"['LRRC25', 'COLEC11', 'CRACR2A', 'ALOX5', 'S100A6', 'TNFRSF11B', 'CD14', 'HLA-DRB1']",0.9979003388417151,0,0,8
168,Integrin-mediated Cell Adhesion WP185,0.5754395001919315,0.9896155631188119,0.5468825222066099,"['ITGB2', 'MAPK1', 'ITGAE', 'HRAS', 'PAK4']",0.9979003388417151,0,0,5
169,Alpha 6 Beta 4 signaling pathway WP244,0.5769163587889278,1.0557953144266339,0.5807486397977157,"['MAPK1', 'HRAS']",0.9979003388417151,0,0,2
170,Toll-like Receptor Signaling related to MyD88 WP3858,0.5769163587889278,1.0557953144266339,0.5807486397977157,"['TLR1', 'MAPK1']",0.9979003388417151,0,0,2
171,Corticotropin-releasing hormone signaling pathway WP2355,0.5937612283415085,0.9743272796424836,0.507895388266887,"['POMC', 'IL18', 'CRH', 'MAPK1']",0.9979003388417151,0,0,4
172,Hippo-Merlin Signaling Dysregulation WP4541,0.5967045368621132,0.9618370900192932,0.49662842374972505,"['NTRK2', 'ITGB2', 'ITGAE', 'HRAS', 'CDH8', 'PAK4']",0.9979003388417151,0,0,6
173,Fibrin Complement Receptor 3 Signaling Pathway WP4136,0.5977696222605247,1.0134648581997534,0.521478187031521,"['ITGB2', 'CD14']",0.9979003388417151,0,0,2
174,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.5977696222605247,1.0134648581997534,0.521478187031521,"['MAPK1', 'HRAS']",0.9979003388417151,0,0,2
175,Transcriptional cascade regulating adipogenesis WP4211,0.5983655700152213,1.1518137035378415,0.5915178329255194,['DDIT3'],0.9979003388417151,0,0,1
176,Cells and molecules involved in local acute inflammatory response  WP4493,0.5983655700152213,1.1518137035378415,0.5915178329255194,['ITGB2'],0.9979003388417151,0,0,1
177,Cholesterol Biosynthesis Pathway WP197,0.5983655700152213,1.1518137035378415,0.5915178329255194,['PMVK'],0.9979003388417151,0,0,1
178,Methionine De Novo and Salvage Pathway WP3580,0.5983655700152213,1.1518137035378415,0.5915178329255194,['TXN'],0.9979003388417151,0,0,1
179,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.6022946787838348,0.9743589743589743,0.49400823703420366,"['IFI27L2', 'MAPK1', 'HRAS']",0.9979003388417151,0,0,3
180,Oncostatin M Signaling Pathway WP2374,0.6022946787838348,0.9743589743589743,0.49400823703420366,"['RPS6', 'MAPK1', 'HRAS']",0.9979003388417151,0,0,3
181,Prolactin Signaling Pathway WP2037,0.607958386215962,0.9558504559554073,0.4756778735657018,"['RPS6', 'MAPK1', 'PPIB', 'HRAS']",0.9979003388417151,0,0,4
182,Fas ligand pathway and stress induction of heat shock proteins WP314,0.6178405887347984,0.9743905909134023,0.46919323619417785,"['ARHGDIB', 'CYCS']",0.9979003388417151,0,0,2
183,Serotonin Receptor 4/6/7 and NR3C Signaling WP734,0.6277824887918755,1.0557266009852218,0.49150568943713013,['MAPK1'],0.9979003388417151,0,0,1
184,Sphingolipid Metabolism (general overview) WP4725,0.6277824887918755,1.0557266009852218,0.49150568943713013,['CERS6'],0.9979003388417151,0,0,1
185,Sphingolipid Metabolism (integrated pathway) WP4726,0.6277824887918755,1.0557266009852218,0.49150568943713013,['CERS6'],0.9979003388417151,0,0,1
186,Intraflagellar transport proteins binding to dynein WP4532,0.6277824887918755,1.0557266009852218,0.49150568943713013,['IFT22'],0.9979003388417151,0,0,1
187,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,0.6277824887918755,1.0557266009852218,0.49150568943713013,['SCO2'],0.9979003388417151,0,0,1
188,PI3K/AKT/mTOR - VitD3 signaling WP4141,0.6277824887918755,1.0557266009852218,0.49150568943713013,['HLA-DRA'],0.9979003388417151,0,0,1
189,DNA Replication WP466,0.6371319688053534,0.9382107137964105,0.4229251924373193,"['POLD4', 'RFC2']",0.9979003388417151,0,0,2
190,IL-5 signaling pathway WP127,0.6371319688053534,0.9382107137964105,0.4229251924373193,"['RPS6', 'MAPK1']",0.9979003388417151,0,0,2
191,Nuclear Receptors Meta-Pathway WP2882,0.6406364407188736,0.9292796610169491,0.41380187504180094,"['SERPINA1', 'DBI', 'TXN', 'SLC6A20', 'SLC5A3', 'PSMC5', 'SLC6A9', 'FTH1', 'SLCO2B1', 'ALOX5AP', 'ME1', 'BAX', 'FTL']",0.9979003388417151,0,0,13
192,ErbB signaling pathway WP673,0.6486777805804229,0.9043793042556949,0.3914327012589973,"['MAPK1', 'HRAS', 'CRKL', 'PAK4']",0.9979003388417151,0,0,4
193,Ebola Virus Pathway on Host WP4217,0.650138217988988,0.9042609618104668,0.38934790966045746,"['HLA-B', 'HLA-DRA', 'MAPK1', 'HLA-DOA', 'HLA-DRB1']",0.9979003388417151,0,0,5
194,Cancer immunotherapy by PD-1 blockade WP4585,0.6550472709396372,0.9744221295945434,0.41222721281507485,['HLA-DRB1'],0.9979003388417151,0,0,1
195,Extracellular vesicles in the crosstalk of cardiac cells WP4300,0.6550472709396372,0.9744221295945434,0.41222721281507485,['CD63'],0.9979003388417151,0,0,1
196,Physiological and pathological hypertrophy of the heart WP1528,0.6550472709396372,0.9744221295945434,0.41222721281507485,['MAPK1'],0.9979003388417151,0,0,1
197,PPAR-alpha pathway WP2878,0.6550472709396372,0.9744221295945434,0.41222721281507485,['DBI'],0.9979003388417151,0,0,1
198,Aryl Hydrocarbon Receptor Netpath WP2586,0.6556502602217441,0.9046151136163466,0.38186316253110403,"['MAPK1', 'HRAS']",0.9979003388417151,0,0,2
199,Wnt Signaling Pathway WP363,0.6556502602217441,0.9046151136163466,0.38186316253110403,"['RYK', 'MAPK1']",0.9979003388417151,0,0,2
200,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.6556502602217441,0.9046151136163466,0.38186316253110403,"['MAPK1', 'HRAS']",0.9979003388417151,0,0,2
201,Metabolic reprogramming in colon cancer WP4290,0.6556502602217441,0.9046151136163466,0.38186316253110403,"['IDH2', 'SLC1A5']",0.9979003388417151,0,0,2
202,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.6734051803947803,0.8733364513797355,0.345324288902048,"['ITGB2', 'PAK4']",0.9979003388417151,0,0,2
203,Neural Crest Cell Migration in Cancer WP4565,0.6734051803947803,0.8733364513797355,0.345324288902048,"['NTRK2', 'PAK4']",0.9979003388417151,0,0,2
204,Thermogenesis WP4321,0.6742141984211905,0.8730233152892034,0.3441522658794247,"['RPS6', 'FRS2', 'CPT1B', 'HRAS']",0.9979003388417151,0,0,4
205,Circadian rhythm related genes WP3594,0.6773706839892396,0.8878718535469108,0.34585859797135965,"['KDM5A', 'CAVIN3', 'CRH', 'DRD1', 'BTRC', 'RPS27A', 'BTBD9', 'HCRTR1']",0.9979003388417151,0,0,8
206,Melanoma WP4685,0.6786054395805325,0.8632154882154882,0.3346819476031432,"['MAPK1', 'BAX', 'HRAS']",0.9979003388417151,0,0,3
207,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.6786054395805325,0.8632154882154882,0.3346819476031432,"['MAPK1', 'BAX', 'HRAS']",0.9979003388417151,0,0,3
208,Signal Transduction of S1P Receptor WP26,0.6803171863814714,0.9047325826882477,0.3484994976837544,['MAPK1'],0.9979003388417151,0,0,1
209,TGF-B Signaling in Thyroid Cells for Epithelial-Mesenchymal Transition WP3859,0.6803171863814714,0.9047325826882477,0.3484994976837544,['MAPK1'],0.9979003388417151,0,0,1
210,miRNA regulation of p53 pathway in prostate cancer WP3982,0.6803171863814714,0.9047325826882477,0.3484994976837544,['BAX'],0.9979003388417151,0,0,1
211,miRNA targets in ECM and membrane receptors WP2911,0.6803171863814714,0.9047325826882477,0.3484994976837544,['COL4A1'],0.9979003388417151,0,0,1
212,Proteoglycan biosynthesis WP4784,0.6803171863814714,0.9047325826882477,0.3484994976837544,['EXT2'],0.9979003388417151,0,0,1
213,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.6904091616177288,0.8441430332922318,0.31273040334623103,"['PPP1R14B', 'DDIT3']",0.9979003388417151,0,0,2
214,Prostaglandin Synthesis and Regulation WP98,0.6904091616177288,0.8441430332922318,0.31273040334623103,"['S100A6', 'PTGS1']",0.9979003388417151,0,0,2
215,Simplified Depiction of MYD88 Distinct Input-Output Pathway WP3877,0.703738025553924,0.8443349753694581,0.29665634625126436,['TLR1'],0.9979003388417151,0,0,1
216,Statin inhibition of cholesterol production WP430,0.703738025553924,0.8443349753694581,0.29665634625126436,['APOC1'],0.9979003388417151,0,0,1
217,Purinergic signaling WP4900,0.703738025553924,0.8443349753694581,0.29665634625126436,['P2RX6'],0.9979003388417151,0,0,1
218,Regulation of apoptosis by parathyroid hormone-related protein WP3872,0.703738025553924,0.8443349753694581,0.29665634625126436,['BAX'],0.9979003388417151,0,0,1
219,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.7059208412529389,0.8255233494363929,0.2874902983604488,"['MAPK1', 'CYCS', 'BAX']",0.9979003388417151,0,0,3
220,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.7066769030483321,0.8168330615329541,0.283589502880387,"['RPS6', 'MAPK1']",0.9979003388417151,0,0,2
221,Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203,0.7222249728796049,0.7912299630086314,0.2574809403833705,"['RPS6', 'MAPK1']",0.9979003388417151,0,0,2
222,Genotoxicity pathway WP4286,0.7222249728796049,0.7912299630086314,0.2574809403833705,"['RPS27', 'TRIAP1']",0.9979003388417151,0,0,2
223,Cannabinoid receptor signaling WP3869,0.725444936311023,0.7914870689655172,0.25404368930278426,['MAPK1'],0.9979003388417151,0,0,1
224,Eicosanoid metabolism via cyclooxygenases (COX) WP4719,0.725444936311023,0.7914870689655172,0.25404368930278426,['PTGS1'],0.9979003388417151,0,0,1
225,EPO Receptor Signaling WP581,0.725444936311023,0.7914870689655172,0.25404368930278426,['MAPK1'],0.9979003388417151,0,0,1
226,FGFR3 signaling in chondrocyte proliferation and terminal differentiation WP4767,0.725444936311023,0.7914870689655172,0.25404368930278426,['MAPK1'],0.9979003388417151,0,0,1
227,Hypothesized Pathways in Pathogenesis of Cardiovascular Disease WP3668,0.725444936311023,0.7914870689655172,0.25404368930278426,['MAPK1'],0.9979003388417151,0,0,1
228,IL-7 signaling pathway WP205,0.725444936311023,0.7914870689655172,0.25404368930278426,['MAPK1'],0.9979003388417151,0,0,1
229,Hematopoietic Stem Cell Differentiation WP2849,0.7370714570546931,0.7671785674251765,0.2340434991626774,"['RHOH', 'ACVR1B']",0.9979003388417151,0,0,2
230,Lung fibrosis WP3624,0.7370714570546931,0.7671785674251765,0.2340434991626774,"['SERPINA1', 'FGF1']",0.9979003388417151,0,0,2
231,Breast cancer pathway WP4262,0.7405736683604173,0.815925170883799,0.24504694169158361,"['FGF17', 'MAPK1', 'BAX', 'FGF1', 'HRAS', 'DLL3']",0.9979003388417151,0,0,6
232,Eicosanoid metabolism via lipooxygenases (LOX) WP4721,0.7455631999828498,0.7448565633149812,0.21870133772508535,['ALOX5'],0.9979003388417151,0,0,1
233,Estrogen signaling pathway WP712,0.7455631999828498,0.7448565633149812,0.21870133772508535,['MAPK1'],0.9979003388417151,0,0,1
234,RAS and bradykinin pathways in COVID-19 WP4969,0.7455631999828498,0.7448565633149812,0.21870133772508535,['MAPK1'],0.9979003388417151,0,0,1
235,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.7512356492080339,0.7445419598172192,0.2129657264867992,"['MAPK1', 'RNF7']",0.9979003388417151,0,0,2
236,Interferon type I signaling pathways WP585,0.7512356492080339,0.7445419598172192,0.2129657264867992,"['RPS6', 'CRKL']",0.9979003388417151,0,0,2
237,Pathogenic Escherichia coli infection WP2272,0.7512356492080339,0.7445419598172192,0.2129657264867992,"['ARPC1B', 'CD14']",0.9979003388417151,0,0,2
238,MAPK Signaling Pathway WP382,0.762865049486322,0.8258247259053061,0.22352939057269844,"['FGF17', 'CACNA1I', 'NTRK2', 'DDIT3', 'RRAS2', 'MAPK1', 'CD14', 'FGF1', 'HRAS', 'CRKL']",0.9979003388417151,0,0,10
239,Angiogenesis WP1539,0.764208950698056,0.7034072249589491,0.18915607267150347,['MAPK1'],0.9979003388417151,0,0,1
240,Canonical and non-canonical Notch signaling WP3845,0.764208950698056,0.7034072249589491,0.18915607267150347,['DLL3'],0.9979003388417151,0,0,1
241,Unfolded protein response WP4925,0.764208950698056,0.7034072249589491,0.18915607267150347,['DDIT3'],0.9979003388417151,0,0,1
242,Imatinib and Chronic Myeloid Leukemia WP3640,0.764208950698056,0.7034072249589491,0.18915607267150347,['SKP2'],0.9979003388417151,0,0,1
243,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.764208950698056,0.7034072249589491,0.18915607267150347,['FTL'],0.9979003388417151,0,0,1
244,PDGFR-beta pathway WP3972,0.764208950698056,0.7034072249589491,0.18915607267150347,['HRAS'],0.9979003388417151,0,0,1
245,Photodynamic therapy-induced unfolded protein response WP3613,0.764208950698056,0.7034072249589491,0.18915607267150347,['DDIT3'],0.9979003388417151,0,0,1
246,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.7647377773669546,0.7231988726440021,0.19397804950151876,"['PSMC5', 'PSMD7']",0.9979003388417151,0,0,2
247,Ras signaling WP4223,0.769407598462235,0.7971296358393133,0.20895510908356144,"['NTRK2', 'RASA3', 'RRAS2', 'MAPK1', 'RASAL2', 'HRAS', 'PAK4']",0.9979003388417151,0,0,7
248,Synaptic Vesicle Pathway WP2267,0.7775987646619956,0.7030415125359638,0.1768463062427391,"['SLC32A1', 'PARK7']",0.9979003388417151,0,0,2
249,Netrin-UNC5B signaling pathway WP4747,0.7775987646619956,0.7030415125359638,0.1768463062427391,"['DAPK1', 'MAPK1']",0.9979003388417151,0,0,2
250,RANKL/RANK signaling pathway WP2018,0.7775987646619956,0.7030415125359638,0.1768463062427391,"['MAPK1', 'TNFRSF11B']",0.9979003388417151,0,0,2
251,Sphingolipid pathway WP1422,0.781489842614134,0.6663209748509205,0.16428351960191934,['CERS6'],0.9979003388417151,0,0,1
252,Fatty acid beta-oxidation WP143,0.781489842614134,0.6663209748509205,0.16428351960191934,['CPT1B'],0.9979003388417151,0,0,1
253,Oxidative Stress WP408,0.781489842614134,0.6663209748509205,0.16428351960191934,['CYBB'],0.9979003388417151,0,0,1
254,Pregnane X receptor pathway WP2876,0.781489842614134,0.6663209748509205,0.16428351960191934,['PSMC5'],0.9979003388417151,0,0,1
255,Resistin as a regulator of inflammation WP4481,0.781489842614134,0.6663209748509205,0.16428351960191934,['MAPK1'],0.9979003388417151,0,0,1
256,ESC Pluripotency Pathways WP3931,0.7822434013924883,0.7439104195448266,0.18269646292128036,"['FGF17', 'MAPK1', 'FGF1', 'HRAS']",0.9979003388417151,0,0,4
257,Apoptosis WP254,0.7875437812228421,0.7160027952480783,0.1710074688776022,"['TRADD', 'CYCS', 'BAX']",0.9979003388417151,0,0,3
258,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,0.797505668539308,0.6329433497536946,0.14321377293682988,['SUPT4H1'],0.9979003388417151,0,0,1
259,SARS-CoV-2 mitochondrial interactions WP5038,0.797505668539308,0.6329433497536946,0.14321377293682988,['NDUFB9'],0.9979003388417151,0,0,1
260,Aryl Hydrocarbon Receptor Pathway WP2873,0.8123489330219715,0.6027445460942998,0.12526557253672058,['BAX'],0.9979003388417151,0,0,1
261,Cell migration and invasion through p75NTR WP4561,0.8123489330219715,0.6027445460942998,0.12526557253672058,['NTRK2'],0.9979003388417151,0,0,1
262,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.8123489330219715,0.6027445460942998,0.12526557253672058,['HRAS'],0.9979003388417151,0,0,1
263,miRNA regulation of prostate cancer signaling pathways WP3981,0.8123489330219715,0.6027445460942998,0.12526557253672058,['MAPK1'],0.9979003388417151,0,0,1
264,Monoamine Transport WP727,0.8123489330219715,0.6027445460942998,0.12526557253672058,['TNFRSF11B'],0.9979003388417151,0,0,1
265,Prion disease pathway WP3995,0.8123489330219715,0.6027445460942998,0.12526557253672058,['MAPK1'],0.9979003388417151,0,0,1
266,Metapathway biotransformation Phase I and II WP702,0.812679211667259,0.7263571184704677,0.1506601370610917,"['GSTK1', 'CYP2C8', 'GSTO1', 'AKR1A1', 'HS6ST3']",0.9979003388417151,0,0,5
267,Toll-like Receptor Signaling Pathway WP75,0.8163000358947666,0.6774470899470899,0.13750367179611814,"['TLR1', 'MAPK1', 'CD14']",0.9979003388417151,0,0,3
268,Proximal tubule transport WP4917,0.8230630830326923,0.6324907521578298,0.1231601369350424,"['SLC7A7', 'SLC6A20']",0.9979003388417151,0,0,2
269,Androgen receptor signaling pathway WP138,0.8251222443741835,0.6654970760233918,0.12792432934243556,"['SUMO1', 'BAG1', 'PARK7']",0.9979003388417151,0,0,3
270,Vitamin D-sensitive calcium signaling in depression WP4698,0.8261053842641156,0.5752910882221227,0.10989954203893074,['KCNQ2'],0.9979003388417151,0,0,1
271,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.8261053842641156,0.5752910882221227,0.10989954203893074,['BAX'],0.9979003388417151,0,0,1
272,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.833043292138813,0.6170039998797029,0.11270791507885797,"['TMSB4X', 'MAPK1']",0.9979003388417151,0,0,2
273,EGF/EGFR signaling pathway WP437,0.8374926487148705,0.7149470435575507,0.1267907055339476,"['NDUFA13', 'GRB10', 'MAPK1', 'NEDD8', 'HRAS', 'CRKL']",0.9979003388417151,0,0,6
274,Amyotrophic lateral sclerosis (ALS) WP2447,0.8388545069325244,0.5502248875562219,0.09668441680742089,['BAX'],0.9979003388417151,0,0,1
275,White fat cell differentiation WP4149,0.8388545069325244,0.5502248875562219,0.09668441680742089,['DDIT3'],0.9979003388417151,0,0,1
276,Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839,0.8388545069325244,0.5502248875562219,0.09668441680742089,['FGF1'],0.9979003388417151,0,0,1
277,IL17 signaling pathway WP2112,0.8506699792700004,0.5272475369458128,0.0852722867232728,['MAPK1'],0.9979003388417151,0,0,1
278,DNA damage response WP707,0.8514919093016371,0.5881914375017923,0.09456076151148611,"['CYCS', 'BAX']",0.9979003388417151,0,0,2
279,"GPCRs, Class A Rhodopsin-like WP455",0.8529153005355296,0.7126490834867526,0.11337892902219866,"['CHRM3', 'GPR65', 'PTAFR', 'CHRM5', 'OR6A2', 'DRD1', 'HCRTR1']",0.9979003388417151,0,0,7
280,MECP2 and Associated Rett Syndrome WP3584,0.8600024326532074,0.5747674027575383,0.08668645478612357,"['SST', 'RPS6']",0.9979003388417151,0,0,2
281,miRNA regulation of DNA damage response WP1530,0.8600024326532074,0.5747674027575383,0.08668645478612357,"['CYCS', 'BAX']",0.9979003388417151,0,0,2
282,G13 Signaling Pathway WP524,0.8616200965777799,0.5061083743842365,0.07538020068930766,['ARHGDIB'],0.9979003388417151,0,0,1
283,Rett syndrome causing genes WP4312,0.8616200965777799,0.5061083743842365,0.07538020068930766,['GPS2'],0.9979003388417151,0,0,1
284,Male infertility WP4673,0.8639733251566847,0.6115292712066905,0.08941376435138279,"['EPSTI1', 'HLA-DRA', 'PEX10']",0.9979003388417151,0,0,3
285,Pancreatic adenocarcinoma pathway WP4263,0.8707654712133209,0.6017636684303351,0.08327362235103469,"['MAPK1', 'BAX', 'PAK4']",0.9979003388417151,0,0,3
286,Tryptophan metabolism WP465,0.8717681643457245,0.4865953012504737,0.06677632813754691,['HSD17B10'],0.9979003388417151,0,0,1
287,IL-6 signaling pathway WP364,0.8717681643457245,0.4865953012504737,0.06677632813754691,['MAPK1'],0.9979003388417151,0,0,1
288,Notch Signaling WP268,0.8717681643457245,0.4865953012504737,0.06677632813754691,['DLL3'],0.9979003388417151,0,0,1
289,Spinal Cord Injury WP2431,0.8720332516785646,0.6315822002472188,0.08648111265641444,"['COL4A1', 'APEX1', 'TNFSF13', 'MAPK1']",0.9979003388417151,0,0,4
290,B Cell Receptor Signaling Pathway WP23,0.8772562401477646,0.5923032407407407,0.07756575277321692,"['MAPK1', 'HRAS', 'CRKL']",0.9979003388417151,0,0,3
291,TGF-beta Signaling Pathway WP366,0.8778292669698062,0.6237238474568512,0.08127318892119215,"['PARD6A', 'SUMO1', 'MAPK1', 'BTRC']",0.9979003388417151,0,0,4
292,Integrated Cancer Pathway WP1971,0.8811728619815443,0.46852764094143406,0.05926943118702501,['BAX'],0.9979003388417151,0,0,1
293,Neovascularisation processes WP4331,0.8811728619815443,0.46852764094143406,0.05926943118702501,['MAPK1'],0.9979003388417151,0,0,1
294,NO/cGMP/PKG mediated Neuroprotection WP4008,0.8811728619815443,0.46852764094143406,0.05926943118702501,['CYCS'],0.9979003388417151,0,0,1
295,Oxidation by Cytochrome P450 WP43,0.8811728619815443,0.46852764094143406,0.05926943118702501,['CYP2C8'],0.9979003388417151,0,0,1
296,Oxidative Damage WP3941,0.8811728619815443,0.46852764094143406,0.05926943118702501,['CYCS'],0.9979003388417151,0,0,1
297,Regulation of Microtubule Cytoskeleton WP2038,0.8811728619815443,0.46852764094143406,0.05926943118702501,['PARD6A'],0.9979003388417151,0,0,1
298,AGE/RAGE pathway WP2324,0.8829226269820875,0.5379227116509694,0.06698090280205363,"['MAPK1', 'CYCS']",0.9979003388417151,0,0,2
299,Regulatory circuits of the STAT3 signaling pathway WP4538,0.889757034495642,0.5266646115906288,0.061518033482986165,"['CSF3R', 'MAPK1']",0.9979003388417151,0,0,2
300,TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway WP2036,0.8898885808088858,0.45175052779732583,0.05270077123502534,['MAPK1'],0.9979003388417151,0,0,1
301,Differentiation Pathway WP2848,0.8898885808088858,0.45175052779732583,0.05270077123502534,['FGF1'],0.9979003388417151,0,0,1
302,DNA IR-double strand breaks and cellular response via ATM WP3959,0.8898885808088858,0.45175052779732583,0.05270077123502534,['BAX'],0.9979003388417151,0,0,1
303,Neural Crest Cell Migration during Development WP4564,0.8898885808088858,0.45175052779732583,0.05270077123502534,['PAK4'],0.9979003388417151,0,0,1
304,Small cell lung cancer WP4658,0.8950240429273381,0.565616362631288,0.06272951157725769,"['COL4A1', 'CYCS', 'BAX']",0.9979003388417151,0,0,3
305,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.8961389769471354,0.7106848263955496,0.07793353448798447,"['FGF17', 'CSF3R', 'CAB39L', 'COL4A1', 'RPS6', 'ITGB2', 'VEGFB', 'MAPK1', 'ITGAE', 'FGF1', 'HRAS']",0.9979003388417151,0,0,11
306,Pre-implantation embryo WP3527,0.897965737130109,0.4361304569390182,0.04693782781330166,['DDIT3'],0.9979003388417151,0,0,1
307,Myometrial relaxation and contraction pathways WP289,0.9044085423953887,0.6125636835528213,0.06154678066277432,"['RGS19', 'GSTO1', 'CRH', 'IGFBP6', 'RGS6']",0.9979003388417151,0,0,5
308,Vitamin A and carotenoid metabolism WP716,0.9054510620266267,0.421551724137931,0.04186938073469937,['MAPK1'],0.9979003388417151,0,0,1
309,Integrated breast cancer pathway WP1984,0.9080356132275957,0.580367418268616,0.055989019587008644,"['TRADD', 'MAPK1', 'BAX', 'FAU']",0.9979003388417151,0,0,4
310,"GPCRs, Other WP117",0.9080997665607544,0.4955392761296874,0.04777049729321371,"['CHRM3', 'ADGRL2']",0.9979003388417151,0,0,2
311,Exercise-induced Circadian Regulation WP410,0.9123878705340037,0.40791355474336566,0.03740162756178264,['SUMO1'],0.9979003388417151,0,0,1
312,Head and Neck Squamous Cell Carcinoma WP4674,0.9135509642902576,0.4859622498340131,0.04393881846408679,"['RPS6', 'HRAS']",0.9979003388417151,0,0,2
313,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.9188163115445401,0.3951277709359606,0.03345509505982868,['CD4'],0.9979003388417151,0,0,1
314,Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) WP4718,0.9188163115445401,0.3951277709359606,0.03345509505982868,['PMVK'],0.9979003388417151,0,0,1
315,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.9188163115445401,0.3951277709359606,0.03345509505982868,['BAX'],0.9979003388417151,0,0,1
316,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.9188163115445401,0.3951277709359606,0.03345509505982868,['TRADD'],0.9979003388417151,0,0,1
317,DNA damage response (only ATM dependent) WP710,0.9195553912241221,0.5260802469135802,0.044119717887466624,"['MAPK1', 'BAX', 'HRAS']",0.9979003388417151,0,0,3
318,Gastrin signaling pathway WP4659,0.9237851744873683,0.5188229325215626,0.041130066464851574,"['RPS6', 'MAPK1', 'HRAS']",0.9979003388417151,0,0,3
319,Osteoblast differentiation WP4787,0.9278104348389595,0.5117617617617618,0.03834520333447549,"['MAPK1', 'FGF1', 'DLL3']",0.9979003388417151,0,0,3
320,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.9279411398210397,0.5485569946794218,0.04102491831545577,"['COL4A1', 'MAPK1', 'HRAS', 'DLL3']",0.9979003388417151,0,0,4
321,Retinoblastoma gene in cancer WP2446,0.9281382614349015,0.4593207039569555,0.03425364338266845,"['H2AFZ', 'SKP2']",0.9979003388417151,0,0,2
322,Sterol regulatory element-binding proteins (SREBP) signaling WP1982,0.9302942231800615,0.37181251811069255,0.02686508068870627,['DBI'],0.9979003388417151,0,0,1
323,Hepatitis B infection WP4666,0.9314227195793534,0.5426053670401532,0.03854780076085062,"['CYCS', 'MAPK1', 'BAX', 'HRAS']",0.9979003388417151,0,0,4
324,Glioblastoma signaling pathways WP2261,0.9324609343995854,0.4510745111854853,0.031542748227691486,"['MAPK1', 'HRAS']",0.9979003388417151,0,0,2
325,TGF-beta Receptor Signaling WP560,0.9354101563516231,0.36115411681914145,0.02411432393814591,['HRAS'],0.9979003388417151,0,0,1
326,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.9354101563516231,0.36115411681914145,0.02411432393814591,['TRADD'],0.9979003388417151,0,0,1
327,Phosphodiesterases in neuronal function WP4222,0.9354101563516231,0.36115411681914145,0.02411432393814591,['DRD1'],0.9979003388417151,0,0,1
328,Structural Pathway of Interleukin 1 (IL-1) WP2637,0.9401510298603608,0.3510878489326765,0.021667297617149795,['MAPK1'],0.9979003388417151,0,0,1
329,Cardiac Hypertrophic Response WP2795,0.9401510298603608,0.3510878489326765,0.021667297617149795,['MAPK1'],0.9979003388417151,0,0,1
330,IL-4 signaling pathway WP395,0.9401510298603608,0.3510878489326765,0.021667297617149795,['MAPK1'],0.9979003388417151,0,0,1
331,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.9445443086750982,0.34156570363466915,0.019487239072871265,['HRAS'],0.9979003388417151,0,0,1
332,IL-1 signaling pathway WP195,0.9445443086750982,0.34156570363466915,0.019487239072871265,['MAPK1'],0.9979003388417151,0,0,1
333,Notch Signaling Pathway Netpath WP61,0.9445443086750982,0.34156570363466915,0.019487239072871265,['DLL3'],0.9979003388417151,0,0,1
334,Pathways in clear cell renal cell carcinoma WP4018,0.9474093837430968,0.42083847102342786,0.02273537074500005,"['ME1', 'GRB10']",0.9979003388417151,0,0,2
335,Regulation of toll-like receptor signaling pathway WP1449,0.9481267585629221,0.47310185185185183,0.025200751400123872,"['TLR1', 'MAPK1', 'CD14']",0.9979003388417151,0,0,3
336,Focal Adhesion WP306,0.9512505591960394,0.5597686906237093,0.027975997563826127,"['COL4A1', 'VEGFB', 'MAPK1', 'HRAS', 'CRKL', 'PAK4']",0.9979003388417151,0,0,6
337,Calcium Regulation in the Cardiac Cell WP536,0.9518232236279266,0.5042768850432633,0.024899150715729103,"['CHRM3', 'RGS19', 'CHRM5', 'RGS6']",0.9979003388417151,0,0,4
338,The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,0.9558839624192947,0.31585591133004925,0.01425102437947525,['TNFRSF11B'],0.9979003388417151,0,0,1
339,Glucocorticoid Receptor Pathway WP2880,0.9558839624192947,0.31585591133004925,0.01425102437947525,['ALOX5AP'],0.9979003388417151,0,0,1
340,Peptide GPCRs WP24,0.9558839624192947,0.31585591133004925,0.01425102437947525,['HCRTR1'],0.9979003388417151,0,0,1
341,Senescence and Autophagy in Cancer WP615,0.9564923518066387,0.4006811109153896,0.01782329196847903,"['MAPK1', 'HRAS']",0.9979003388417151,0,0,2
342,AMP-activated protein kinase (AMPK) signaling WP1403,0.959123471519932,0.30812207136849695,0.012859617033262417,['CPT1B'],0.9979003388417151,0,0,1
343,Complement and Coagulation Cascades WP558,0.96212535630072,0.3007565095003519,0.011612367872113871,['SERPINA1'],0.9979003388417151,0,0,1
344,Pathways Regulating Hippo Signaling WP4540,0.9640625050934017,0.3823562380899002,0.01399391222733117,"['NTRK2', 'CDH8']",0.9979003388417151,0,0,2
345,Pathways affected in adenoid cystic carcinoma WP3651,0.9649070269874471,0.2937335319051438,0.01049319786807631,['HRAS'],0.9979003388417151,0,0,1
346,PI3K-Akt signaling pathway WP4172,0.9652941885720284,0.5982921188400641,0.02113309288501495,"['FGF17', 'NTRK2', 'CSF3R', 'COL4A1', 'RPS6', 'VEGFB', 'MAPK1', 'COL9A3', 'FGF1', 'HRAS']",0.9979003388417151,0,0,10
347,Fragile X Syndrome  WP4549,0.9683880551517671,0.3710379342859215,0.011918624716634067,"['NTRK2', 'MAPK1']",0.9979003388417151,0,0,2
348,Chemokine signaling pathway WP3929,0.9688516589545827,0.4248855597170204,0.013444979034936579,"['MAPK1', 'HRAS', 'CRKL']",0.9979003388417151,0,0,3
349,Endochondral Ossification with Skeletal Dysplasias WP4808,0.9698730893320677,0.280623973727422,0.008584301888318414,['CTSV'],0.9979003388417151,0,0,1
350,Endochondral Ossification WP474,0.9698730893320677,0.280623973727422,0.008584301888318414,['CTSV'],0.9979003388417151,0,0,1
351,G1 to S cell cycle control WP45,0.9720862964021697,0.2744966802313129,0.0077711921098195256,['MNAT1'],0.9979003388417151,0,0,1
352,16p11.2 proximal deletion syndrome WP4949,0.976037365564408,0.2630080049261084,0.006379103698636286,['TMEM219'],0.9979003388417151,0,0,1
353,Cell cycle WP179,0.9771191540962454,0.34545546678377786,0.007996145492242665,"['SKP2', 'ANAPC11']",0.9979003388417151,0,0,2
354,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.979429715336796,0.2524384236453202,0.0052468821039132465,['MAPK1'],0.9979003388417151,0,0,1
355,Mesodermal commitment pathway WP2857,0.9804520266136629,0.38953799159984726,0.007690088418275693,"['EXT2', 'RPL38', 'AHDC1']",0.9979003388417151,0,0,3
356,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.9809414888811172,0.24746450304259635,0.004761827176457907,['RYK'],0.9979003388417151,0,0,1
357,Insulin Signaling WP481,0.9826298631285327,0.38159371492704824,0.006686578045716114,"['GRB10', 'MAPK1', 'HRAS']",0.9979003388417151,0,0,3
358,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.9845450076535147,0.31903104465498133,0.004969120897055379,"['MAPK1', 'HRAS']",0.9979003388417151,0,0,2
359,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.9848428168930073,0.233648056923919,0.0035685598821028146,['RYK'],0.9979003388417151,0,0,1
360,Endoderm differentiation WP2853,0.9864531709833735,0.3110928437685528,0.004243127356916057,"['AHDC1', 'NME1']",0.9979003388417151,0,0,2
361,G Protein Signaling Pathways WP35,0.9879461992062958,0.2212859735545761,0.002683543180378953,['HRAS'],0.9979003388417151,0,0,1
362,Adipogenesis WP236,0.9888924725915128,0.29989431037519815,0.003349722471791086,"['CELF1', 'DDIT3']",0.9979003388417151,0,0,2
363,Ectoderm Differentiation WP2858,0.9914886100568177,0.2861506557560812,0.002445963919406263,"['TNFRSF11B', 'CDH8']",0.9979003388417151,0,0,2
364,Neural Crest Differentiation WP2064,0.9917728459065426,0.2033410138248848,0.0016798375095923466,['DLL3'],0.9979003388417151,0,0,1
365,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.992553933660025,0.2797369502671599,0.0020907334554390216,"['NTRK2', 'SST']",0.9979003388417151,0,0,2
366,Wnt signaling WP428,0.9951812643489585,0.1825872777896766,0.0008819665174073191,['RYK'],0.9979003388417151,0,0,1
367,Ciliopathies WP4803,0.9998753366375852,0.10717443476064166,1.3361558267861851e-05,['CCDC28B'],0.9998753366375852,0,0,1
